Suh-Chin Wu

Author PubWeight™ 26.08‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Structural basis of a flavivirus recognized by its neutralizing antibody: solution structure of the domain III of the Japanese encephalitis virus envelope protein. J Biol Chem 2003 2.09
2 Is avian influenza A (H7N9) virus staggering its way to humans? J Formos Med Assoc 2013 1.52
3 Review of dengue virus and the development of a vaccine. Biotechnol Adv 2010 1.35
4 A functional epitope determinant on domain III of the Japanese encephalitis virus envelope protein interacted with neutralizing-antibody combining sites. J Virol 2003 1.31
5 High immunogenic enterovirus 71 strain and its production using serum-free microcarrier Vero cell culture. Vaccine 2006 1.24
6 Recombinant trimeric HA protein immunogenicity of H5N1 avian influenza viruses and their combined use with inactivated or adenovirus vaccines. PLoS One 2011 1.10
7 Production of EV71 vaccine candidates. Hum Vaccin Immunother 2012 1.05
8 Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines. Vaccine 2008 0.99
9 Dendritic cell activation by recombinant hemagglutinin proteins of H1N1 and H5N1 influenza A viruses. J Virol 2010 0.94
10 Histidine at residue 99 and the transmembrane region of the precursor membrane prM protein are important for the prM-E heterodimeric complex formation of Japanese encephalitis virus. J Virol 2005 0.92
11 Immunological evaluation and comparison of different EV71 vaccine candidates. Clin Dev Immunol 2012 0.91
12 Characterization of the GXXXG motif in the first transmembrane segment of Japanese encephalitis virus precursor membrane (prM) protein. J Biomed Sci 2010 0.86
13 Production of inactivated influenza H5N1 vaccines from MDCK cells in serum-free medium. PLoS One 2011 0.86
14 Detection of swine-origin influenza A (H1N1) viruses using a localized surface plasmon coupled fluorescence fiber-optic biosensor. Biosens Bioelectron 2010 0.85
15 Broader neutralizing antibodies against H5N1 viruses using prime-boost immunization of hyperglycosylated hemagglutinin DNA and virus-like particles. PLoS One 2012 0.84
16 Fabrication of influenza virus-like particles using M2 fusion proteins for imaging single viruses and designing vaccines. Vaccine 2011 0.81
17 Different immunity elicited by recombinant H5N1 hemagglutinin proteins containing pauci-mannose, high-mannose, or complex type N-glycans. PLoS One 2013 0.81
18 Dengue type 4 live-attenuated vaccine viruses passaged in vero cells affect genetic stability and dengue-induced hemorrhaging in mice. PLoS One 2011 0.81
19 High genetic stability of dengue virus propagated in MRC-5 cells as compared to the virus propagated in vero cells. PLoS One 2008 0.80
20 Mosquito and mammalian cells grown on microcarriers for four-serotype dengue virus production: variations in virus titer, plaque morphology, and replication rate. Biotechnol Bioeng 2004 0.79
21 Heterologous prime-boost immunization regimens using adenovirus vector and virus-like particles induce broadly neutralizing antibodies against H5N1 avian influenza viruses. Biotechnol J 2013 0.79
22 Formulation and immunological evaluation of a trivalent vaccine comprising emulsified submicron particles and inactivated virions of H5N1/EV71/JEV. Hum Vaccin Immunother 2013 0.78
23 Influence of intron and exon splicing enhancers on mammalian cell expression of a truncated spike protein of SARS-CoV and its implication for subunit vaccine development. Vaccine 2005 0.78
24 A novel RNA silencing vector to improve antigen expression and stability in Chinese hamster ovary cells. Vaccine 2007 0.77
25 Identification of a heparin binding peptide from the Japanese encephalitis virus envelope protein. Biopolymers 2010 0.77
26 Generating stable Chinese hamster ovary cell clones to produce a truncated SARS-CoV spike protein for vaccine development. Biotechnol Prog 2010 0.76
27 Identification of mimotopes of the Japanese encephalitis virus envelope protein using phage-displayed combinatorial peptide library. J Mol Microbiol Biotechnol 2004 0.75
28 Construction and characterization of insect cell-derived influenza VLP: cell binding, fusion, and EGFP incorporation. J Biomed Biotechnol 2010 0.75
29 Zika Virus Molecular Biology and Perspectives for Vaccine Development: A Review. J Nurs Res 2017 0.75
30 An intron promotes the anti-bcr-abl activities of a retrovirally expressed ribozyme in chronic myeloid leukemia cells. Biochem Biophys Res Commun 2004 0.75
31 A novel E1B-55kD-deleted oncolytic adenovirus carrying mutant KRAS-regulated hdm2 transgene exerts specific antitumor efficacy on colorectal cancer cells. Mol Cancer Ther 2010 0.75
32 Enhanced antibody affinity to Japanese encephalitis virus E protein by phage display. Biochem Biophys Res Commun 2007 0.75
33 Using recombinant DNA technology for the development of live-attenuated dengue vaccines. Enzyme Microb Technol 2012 0.75